Correction to: Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation

Correction to: Gastric Cancer https://doi.org/10.1007/s10120-021-01194-5

In the original publication of the article, the Figure 1 and Table 1 were published with errors. The corrected Fig. 1 and Table 1 is given in this correction.

Fig. 1

Flowchart depicting the patient selection process. This study included 596 primary GC patients who underwent surgery between January 2006 and December 2016. Among these patients, 193 GC patients were treated without preoperative chemotherapy from 2008 to 2012 and 29 GC patients received preoperative chemotherapy from 2006 to 2016. Among the 69 GC patients with pathological stage II–III without preoperative chemotherapy, 36 patients completed postoperative adjuvant chemotherapy, 12 patients were treated with noncompleted postoperative adjuvant chemotherapy, and 21 patients did not receive postoperative adjuvant chemotherapy. GC gastric cancer, CD44v9 CD44 variant 9

Table 1 Association between CD44v9 expression in resected specimens and clinicopathological factors in GC patients who underwent surgery without preoperative therapy